Denver, CO, United States of America

Yingqiong Cao

This inventor holds 1 USPTO granted patent. Top assignee: University of Colorado. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingqiong Cao. Retrieved from https://idiyas.com/inventor/yingqiong-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yingqiong Cao in Treating Danon Disease

Introduction

Yingqiong Cao is an accomplished inventor based in Denver, CO (US). He has made significant contributions to the field of genetic medicine, particularly in the treatment of Danon disease. His innovative approaches aim to correct genetic mutations and improve patient outcomes.

Latest Patents

Yingqiong Cao holds a patent for "Methods of treating Danon disease." This technology includes methods for correcting genetic mutations in the LAMP-2 gene and ameliorating at least one Danon disease phenotype, such as defective LAMP-2B-mediated autophagy. The disclosed methods may involve editing a mutated form of the LAMP-2 gene in patients. Techniques like CRISPR editing are utilized to target the mutated gene, potentially restoring mutated LAMP-2 proteins in affected cells, including cardiomyocytes. He has 1 patent related to this groundbreaking work.

Career Highlights

Cao is affiliated with the University of Colorado, where he conducts research and develops innovative treatments. His work has garnered attention for its potential to significantly impact the lives of those affected by Danon disease.

Collaborations

Yingqiong Cao collaborates with notable colleagues, including Congwu Chi and Kunhua Song, to advance research in genetic therapies.

Conclusion

Yingqiong Cao's contributions to the treatment of Danon disease exemplify the power of innovation in medicine. His work not only highlights the importance of genetic research but also offers hope for patients suffering from this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…